Versatile structures of α-synuclein

Frontiers in Molecular Neuroscience

Volumn 9, Issue JUNE, 2016, Pages

  Wang, Chuchu ^a   Zhao, Chunyu ^a   Li, Dan ^a   Tian, Zhiqi ^b,c   Lai, Ying ^d   Diao, Jiajie ^b   Liu, Cong ^a  

^a SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Amyloid; Atomic structure; Parkinson s disease; Protein aggregation; Vesicle trafficking; synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; APOLIPOPROTEIN; COMPLEXIN 1; CYSTEINE STRING PROTEIN; LEUCINE ZIPPER PROTEIN; OLIGOMER; PEPTIDES AND PROTEINS; SNARE PROTEIN; SYNAPTOBREVIN 2; SYNAPTOTAGMIN I; TAU PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ATOMIC FORCE MICROSCOPY; CROSS LINKING; CYTOSOL; ELECTRON SPIN RESONANCE; ELECTROPORATION; ENDOCYTOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIPPOCAMPUS; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REVIEW; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 84978732230     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00048     Document Type: Review

References (68)

1. Bartels, T., Choi, J. G., and Selkoe, D. J. (2011). α-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107-110. doi: 10.1038/nature10324
2. Binolfi, A., Theillet, F.-X., and Selenko, P. (2012). Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature? Biochem. Soc. Trans. 40, 950-954. doi: 10.1042/bst20120096
3. Bodner, C. R., Dobson, C. M., and Bax, A. (2009). Multiple tight phospholipid-binding modes of α-synuclein revealed by solution NMR spectroscopy. J. Mol. Biol. 390, 775-790. doi: 10.1016/j.jmb.2009.05.066
4. Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., et al. (2013). Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4:2575. doi: 10.1038/ncomms3575
5. Brunger, A. T., Cipriano, D. J., and Diao, J. (2015). Towards reconstitution of membrane fusion mediated by SNAREs and other synaptic proteins. Crit. Rev. Biochem. Mol. Biol. 50, 231-241. doi: 10.3109/10409238.2015.1023252
6. Burré, J., Sharma, M., and Südhof, T. C. (2014). α-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U S A 111, E4274-E4283. doi: 10.1073/pnas.1416598111
7. Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., and Südhof, T. C. (2010). α-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663-1667. doi: 10.1126/science.1195227
8. Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A. T., and Südhof, T. C. (2013). Properties of native brain α-synuclein.Nature 498, E4-E6; discussion E6-E7. doi: 10.1038/nature12125
9. Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., and Südhof, T. C. (2005). Alpha-synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123, 383-396. doi: 10.1016/j.cell.2005.09.028
10. Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., et al. (2004). Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169. doi: 10.1016/s0140-6736(04)17103-1
11. Chen, S. W., Drakulic, S., Deas, E., Ouberai, M., Aprile, F. A., Arranz, R., et al. (2015). Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc. Natl. Acad. Sci. U S A 112, E1994-E2003. doi: 10.1073/pnas.1421204112
12. Chen, M., Margittai, M., Chen, J., and Langen, R. (2007). Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J. Biol. Chem. 282, 24970-24979. doi: 10.1074/jbc.m700368200
13. Choi, B.-K., Choi, M.-G., Kim, J.-Y., Yang, Y., Lai, Y., Kweon, D.-H., et al. (2013). Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc. Natl. Acad. Sci. U S A 110, 4087-4092. doi: 10.1073/pnas.1218424110
14. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998). Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449. doi: 10.1074/jbc.273.16.9443
15. Dearborn, A. D., Wall, J. S., Cheng, N., Heymann, J. B., Kajava, A. V., Varkey, J., et al. (2015). α-synuclein amyloid fibrils with two entwined, asymmetrically associated, protofibrils. J. Biol. Chem. 291, 2310-2318. doi: 10.1074/jbc.273.16.9443
16. Der-Sarkissian, A., Jao, C. C., Chen, J., and Langen, R. (2003). Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 37530-37535. doi: 10.1074/jbc.M305266200
17. Dewitt, D. C., and Rhoades, E. (2013). α-synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry 52, 2385-2387. doi: 10.1021/bi4002369
18. Diao, J., Burré, J., Vivona, S., Cipriano, D. J., Sharma, M., Kyoung, M., et al. (2013). Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife 2:e00592. doi: 10.7554/eLife.00592
19. Drescher, M., Godschalk, F., Veldhuis, G., Van Rooijen, B. D., Subramaniam, V., and Huber, M. (2008). Spin-Label EPR on α-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices. Chembiochem 9, 2411-2416. doi: 10.1002/cbic.200800238
20. Eliezer, D., Kutluay, E., Bussell, R. Jr., and Browne, G. (2001). Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073. doi: 10.1006/jmbi.2001.4538
21. Fauvet, B., Mbefo, M. K., Fares, M.-B., Desobry, C., Michael, S., Ardah, M. T., et al. (2012). α-synuclein in central nervous system and from erythrocytes, mammalian cells and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 287, 15345-15364. doi: 10.1074/jbc.M111.318949
22. Ferese, R., Modugno, N., Campopiano, R., Santilli, M., Zampatti, S., Giardina, E., et al. (2015). Four copies of SNCA responsible for autosomal dominant Parkinson's disease in two Italian siblings. Parkinsons Dis. 2015:546462. doi: 10.1155/2015/546462
23. Ferreon, A. C., Gambin, Y., Lemke, E. A., and Deniz, A. A. (2009). Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc. Natl. Acad. Sci. U S A 106, 5645-5650. doi: 10.1073/pnas.0809232106
24. Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., et al. (2014). Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat. Commun. 5:3827. doi: 10.1038/ncomms4827
25. George, J. M., Jin, H., Woods, W. S., and Clayton, D. F. (1995). Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361-372. doi: 10.1016/0896-6273(95)90040-3
26. Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., et al. (2013). Distinct α-synuclein strains differentially promote Tau inclusions in neurons. Cell 154, 103-117. doi: 10.1016/j.cell.2013.05.057
27. Gurry, T., Ullman, O., Fisher, C. K., Perovic, I., Pochapsky, T., and Stultz, C. M. (2013). The dynamic structure of α-synuclein multimers. J. Am. Chem. Soc. 135, 3865-3872. doi: 10.1021/ja310518p
28. Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., and Baldus, M. (2005). Molecular-level secondary structure, polymorphism and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. U S A 102, 15871-15876. doi: 10.1073/pnas.0506109102
29. Hu, R., Diao, J., Li, J., Tang, Z., Li, X., Leitz, J., et al. (2016). Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores. Sci. Rep. 6:20776. doi: 10.1038/srep20776
30. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. A., et al. (1995). The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467-475. doi: 10.1016/0896-6273(95)90302-x
31. Jain, N., Bhasne, K., Hemaswasthi, M., and Mukhopadhyay, S. (2013). Structural and dynamical insights into the membrane-bound α-synuclein. PLoS One 8:e83752. doi: 10.1371/journal.pone.0083752
32. Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., and Langen, R. (2008). Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement. Proc. Natl. Acad. Sci. U S A 105, 19666-19671. doi: 10.1073/pnas.0807826105
33. Karpinar, D. P., Balija, M. B. G., Kügler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., et al. (2009). Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models. EMBO J. 28, 3256-3268. doi: 10.1038/emboj.2009.257
34. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., and Kösel, S. (1998). Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108. doi: 10.1038/ng0298-106
35. Lai, Y., Kim, S., Varkey, J., Lou, X., Song, J.-K., Diao, J., et al. (2014). Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding. Biochemistry 53, 3889-3896. doi: 10.1021/bi5002536
36. Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., et al. (2006). α-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915-11922. doi: 10.1523/JNEUROSCI.3821-06.2006
37. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., and Lansbury, P. T. Jr. (2002). Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291-291. doi: 10.1038/418291a
38. Lashuel, H. A., Overk, C. R., Oueslati, A., and Masliah, E. (2013). The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38-48. doi: 10.1038/nrn3406
39. Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., et al. (2013). G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459-471. doi: 10.1002/ana.23894
40. Liu, C., Zhao, M., Jiang, L., Cheng, P.-N., Park, J., Sawaya, M. R., et al. (2012). Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates. Proc. Natl. Acad. Sci. U S A 109, 20913-20918. doi: 10.1073/pnas.1218792109
41. Lokappa, S. B., and Ulmer, T. S. (2011). α-synuclein populates both elongated and broken helix states on small unilamellar vesicles. J. Biol. Chem. 286, 21450-21457. doi: 10.1074/jbc.M111.224055
42. Maroteaux, L., Campanelli, J., and Scheller, R. (1988). Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
43. Marotta, N. P., Lin, Y. H., Lewis, Y. E., Ambroso, M. R., Zaro, B. W., Roth, M. T., et al. (2015). O-GlcNAc modification blocks the aggregation and toxicity of the Parkinson's disease associated protein α-synuclein. Nat. Chem. 7, 913-920. doi: 10.1038/nchem.2361
44. Miake, H., Mizusawa, H., Iwatsubo, T., and Hasegawa, M. (2002). Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277, 19213-19219. doi: 10.1074/jbc.M110551200
45. Mizuno, N., Varkey, J., Kegulian, N. C., Hegde, B. G., Cheng, N., Langen, R., et al. (2012). Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation. J. Biol. Chem. 287, 29301-29311. doi: 10.1074/jbc.M112.365817
46. Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., et al. (2010). Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79. doi: 10.1016/j.neuron.2009.12.023
47. Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H., Lamberto, G. R., et al. (2014). Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization and influences synuclein-membrane interactions. J. Neurosci. 30, 3184-3198. doi: 10.1523/JNEUROSCI.5922-09.2010
48. Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., et al. (2014). A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol. Aging 35, 2180.e1-2180.e5. doi: 10.1016/j.neurobiolaging.2014.03.024
49. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045
50. Proukakis, C., Dudzik, C. G., Brier, T., MacKay, D. S., Cooper, J. M., Millhauser, G. L., et al. (2013). A novel α-synuclein missense mutation in Parkinson disease. Neurology 80, 1062-1064. doi: 10.1212/WNL.0b013e31828727ba
51. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., et al. (2005). Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U S A 102, 10427-10432. doi: 10.1073/pnas.0502066102
52. Rao, J. N., Jao, C. C., Hegde, B. G., Langen, R., and Ulmer, T. S. (2010). A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins. J. Am. Chem. Soc. 132, 8657-8668. doi: 10.1021/ja100646t
53. Robotta, M., Braun, P., Van Rooijen, B., Subramaniam, V., Huber, M., and Drescher, M. (2011). Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein. Chemphyschem 12, 267-269. doi: 10.1002/cphc.201000815
54. Rodriguez, J. A., Ivanova, M. I., Sawaya, M. R., Cascio, D., Reyes, F. E., Shi, D., et al. (2015). Structure of the toxic core of α-synuclein from invisible crystals. Nature 525, 486-490. doi: 10.1038/nature15368
55. Segrest, J. P., De Loof, H., Dohlman, J. G., Brouillette, C. G., and Anantharamaiah, G. M. (1990). Amphipathic helix motif: classes and properties. Proteins 8, 103-117. doi: 10.1002/prot.340080202
56. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). Alpha-synuclein locus triplication causes Parkinson's disease. Science 302:841. doi: 10.1126/science.1090278
57. Spillantini, M. G., Schmidt, M. L., Lee, V. M. Y., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alpha-synuclein in lewy bodies. Nature 388, 839-840. doi: 10.1038/42166
58. Stroud, J. C., Liu, C., Teng, P. K., and Eisenberg, D. (2012). Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc. Natl. Acad. Sci. U S A 109, 7717-7722. doi: 10.1073/pnas.1203193109
59. Theillet, F. X., Binolfi, A., Bekei, B., Martorana, A., Rose, H. M., Stuiver, M., et al. (2016). Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 530, 45-50. doi: 10.1038/nature16531
60. Tuttle, M. D., Comellas, G., Nieuwkoop, A. J., Covell, D. J., Berthold, D. A., Kloepper, K. D., et al. (2016). Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23, 409-415. doi: 10.1038/nsmb.3194
61. Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., et al. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U S A 90, 11282-11286. doi: 10.1073/pnas.90.23.11282
62. Ulmer, T. S., Bax, A., Cole, N. B., and Nussbaum, R. L. (2005). Structure and dynamics of micelle-bound human α-synuclein. J. Biol. Chem. 280, 9595-9603. doi: 10.1074/jbc.M411805200
63. Uversky, V. N., Li, J., and Fink, A. L. (2001). Metal-triggered structural transformations, aggregation and fibrillation of human α-synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 276, 44284-44296. doi: 10.1074/jbc.M105343200
64. Vilar, M., Chou, H.-T., Lührs, T., Maji, S. K., Riek-Loher, D., Verel, R., et al. (2008). The fold of α-synuclein fibrils. Proc. Natl. Acad. Sci. U S A 105, 8637-8642. doi: 10.1073/pnas.0712179105
65. Wang, L., Das, U., Scott, D. A., Tang, Y., McLean, P. J., and Roy, S. (2014). Alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319-2326. doi: 10.1016/j.cub.2014.08.027
66. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T. (1996). NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715. doi: 10.1021/bi961799n
67. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., et al. (2011). In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U S A 108, 4194-4199. doi: 10.1073/pnas.1100976108
68. Zarranz, J. J., Alegre, J., Gómez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., et al. (2004). The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173. doi: 10.1002/ana.10795